Chemical Profiling, Box–Behnken Optimisation, Antimicrobial Activity, and Molecular Docking Study of Z‐Ligustilide Rich Essential Oil From Himalayan Angelica glauca Edgew. Authors: Balam Singh Bisht, Mahesh Chandra Vishwakarma, Prakash Chandra Mathpal, Jyoti Niwas Pant, Hemant Kumar Joshi, Himanshu Rawat, Chandra Shekhar Mathela Published: 2026 ABSTRACT ABSTRACT Angelica glauca Edgew., a high‐altitude Himalayan medicinal plant, is an important source of bioactive essential oil rich in phthalide derivatives. The present study investigated the influence of environmental conditions and extraction parameters on essential oil yield and chemical composition, with particular emphasis on Z‐ligustilide. Essential oils obtained from roots collected across different altitudes revealed marked variations in yield and phytochemical profile, with plants growing at 3500–3800 m producing the highest concentration of Z‐ligustilide (75.2%). The optimised essential oil exhibited broad‐spectrum antimicrobial activity against both Gram‐negative bacteria (Escherichia coli and Pseudomonas aeruginosa) and Candida species. Molecular docking studies further supported its therapeutic potential by demonstrating strong interactions with microbial target proteins, with binding affinities reaching approximately −6.9 kcal/mol. The predicted mechanisms of antimicrobial action include membrane disruption, interference with ATP production, and inhibition of biofilm formation, indicating a multi‐target mode of action. Overall, these findings demonstrate that altitude‐driven phytochemical variation combined with optimised extraction significantly enhances the quality and biological efficacy of A. glauca root oil, highlighting its potential as a natural antimicrobial agent for pharmaceutical and nutraceutical applications. Introduction The Himalayan region, covering parts of India, Nepal, Bhutan and Tibet, is a biodiversity hotspot with a unique climate that fosters the growth of rich aromatic and medicinal herbs and spices featuring distinct phytochemical properties. These species are not only integral to culinary traditions but also hold significant medicinal potential and economic value. The high‐altitude environment, coupled with organic farming practices, enhances the bioactive compound content, thereby adding to their quality and therapeutic efficacy. Himalayan spices are widely used in traditional medicines like Ayurveda, Unani and Tibetan systems for their antimicrobial, antioxidant and anti‐inflammatory properties [1]. Their essential oils and bioactive compounds have been explored for use in pharmaceuticals and food additives [2, 3]. With increasing global interest in organic and medicinal spices, the sustainable cultivation and conservation of Himalayan spices have gained significant attention. Among these, Angelica glauca Edgew. (Apiaceae), commonly known as ‘Gandrayan’, is highly valued for its root essential oils used in traditional spice, medicine, perfumery and pharmaceuticals. Endemic to the high‐altitude zones of the Himalayas, this species exhibits remarkable adaptability to varying ecological niches [4]. The essential oil of A. glauca has been reported to possess antimicrobial, anti‐inflammatory and antioxidant properties, attributed to its diverse phytochemicals [5, 6, 7, 8]. One of its constituent Z‐ligustilide, is a bioactive phthalide primarily found in medicinal plants of the Apiaceae family, such as Angelica sinensis, A. glauca and Ligusticum chuanxiong. It is well known for its diverse pharmacological activities, including neuroprotective, anti‐inflammatory, antioxidant, antimicrobial, anticancer and cardiovascular benefits [9, 10, 11, 12, 13, 14, 15, 16]. Earlier reports show drastic qualitative and quantitative variations with respect to mono‐ and sesquiterpenoids, bioactive ligustilide, phthalides and their oxygenated derivatives as constituents of A. glauca root oil. Additionally, the influence of environmental and geographical factors on its chemical profile with reference to bioactive constituents is lacking [17, 18, 19, 20, 21, 22, 23, 24, 25]. We report here variations in phytochemical and antimicrobial activities among root oils collected from six geographical regions to assess the suitability of the materials and their commercial potential. Previous studies have reported considerable variation in the chemical composition of A. glauca essential oil due to differences in geographical location, altitude and environmental conditions. Such variability influences the plant's biological activities, including its reported antimicrobial and therapeutic potential. Therefore, the present study focuses on GC–MS chemical profiling, Box–Behnken design (BBD) optimisation and molecular docking study to evaluate the effect of extraction parameters and altitude on the accumulation of phthalide‐rich essential oil and its bioactive potential. Results and Discussion Essential Oil Yield The yield of essential oil varied significantly across locations, ranging from 0.82% (v/w) to 1.45% (v/w) in the samples (Table 1). Moderate yields were observed in plants from high altitude regions, likely due to optimal climatic conditions favouring secondary metabolite synthesis. TABLE 1 Angelica glauca roots essential oil yield (%v/w).AbbreviationCollection site a AltitudeYield (%v/w)AG1Seepu village, b Pithoragarh3470 m1.45AG2Dantu village, b Pithoragarh4115 m0.95AG3Namik village, b Pithoragarh3600 m1.32AG4Munsiyari, b Pithoragarh2400 m0.82AG5Kuti village, b Pithoragarh3700 m1.21AG6Badrinath, c Chamoli3133 m1.13 a Different geographical locations of Uttarakhand (Kumaun and Garhwal region of Himalaya). b Kumaun region of Himalaya, Uttarakhand. c Garhwal region of Himalaya, Uttarakhand.John Wiley & Sons, Ltd. Angelica glauca roots essential oil yield (%v/w). Different geographical locations of Uttarakhand (Kumaun and Garhwal region of Himalaya). Kumaun region of Himalaya, Uttarakhand. Garhwal region of Himalaya, Uttarakhand. Chemical Composition A total of 64 different chemical compounds were identified, with their respective retention indices (LRI) and percentage compositions (FID %; Figures S1–S6) across different samples (AG1–AG6). Z‐Ligustilide has the highest percentage across samples, particularly at 75.2% in the sample collected from Seepu village (AG1), while also showing significant percentages in other samples. E‐Ligustilide is comparatively lower than Z‐ligustilide but still notable; this compound ranges around 3.99%–6.98% across different samples. Senkyunolide H shows variability, with a high of 7.11% in a sample collected from Dantu village (AG2) and lower percentages in other samples. Compounds like α‐phellandrene, limonene and β‐caryophyllene appear, with varying concentrations in each sample. The percentage composition of compounds, such as butyl phthalide and other constituents, varies significantly between samples, reflecting differences in chemical profiles based on source or preparation. Notably, the sample collected from Namik village (AG3) was found to contain maximum amount of Z‐butylidenephthalide (45.39%) while other samples having range 1.85%–13.11%. The total percentages of identified compounds in the samples are AG1: 92.64%, AG2: 95.06%, AG3: 98.97%, AG4: 94.15%, AG5: 97.42%, and AG6: 91.48% (Table 2). Multivariate analysis revealed strong correlations between essential oil composition and environmental factors. Altitude positively influenced the concentration of monoterpenes such as Z‐ligustilide and Z‐butylidenephthalide (Figure 1). This is the first time we are reporting the maximum percentage of Z‐ligustilide 75.2% in a sample collected from Seepu village (AG1). Z‐Ligustilide is a bioactive phthalide compound primarily found in medicinal plants of the Apiaceae family, such as A. sinensis, A. glauca and L. chuanxiong. It is well known for its diverse pharmacological activities, including neuroprotective, anti‐inflammatory, antioxidant, antimicrobial, anticancer and cardiovascular benefits [9, 25, 26, 27]. Z‐Ligustilide has demonstrated antibacterial and antifungal properties, particularly against Staphylococcus aureus and Candida albicans [12]. It also exhibits antiviral potential by inhibiting viral replication in infections such as influenza and herpes simplex virus (HSV). Studies suggest Z‐ligustilide induces apoptosis (programmed cell death) in various cancer cell lines, including lung, breast and colorectal cancer [24]. It improves blood circulation and prevents ischemia‐reperfusion injury, making it beneficial in conditions like stroke, hypertension and atherosclerosis [13]. It acts as a vasodilator, reducing high blood pressure and promoting vascular relaxation. Traditionally, it has been used to relieve menstrual cramps and muscle spasms by relaxing smooth muscles in the uterus and gastrointestinal tract. It reduces pain and inflammation, making it useful for treating headaches and migraines [10]. Thus, the sample collected from Darma village (AG1) is highly valuable due to its maximum concentration of Z‐ligustilide. TABLE 2Terpenoid composition of Himalayan Angelica glauca root oil originating from different geographical regions.S. no.Compound nameRTLRIS [28, 29]LRIRFID %AG1AG2AG3AG4AG5AG61Butyraldehyde2.388929040.120.15————2α‐Thujene5.39924927———0.1——3α‐Pinene5.629329331.30.87—1.150.81—4Sabinene6.689699700.71.92—4.743.292.45(−)‐β‐Pinene6.819749760.50.06————6Myrcene7.20988991—0.07—0.150.070.977α‐Phellandrene7.62100210050.180.12————8Isoascaridol7.7710101011—0.1————9α‐Terpinene8.0710141018———0.06——10 p‐Cymene8.30102010253.51.67—3.870.51—11Limonene8.46102410290.78—12β‐Phellandrene8.4710251031———3.842.94—13α‐Ocimene9.1910441046—0.07—0.7——14 γ‐Terpinene9.5510541057———0.12——15Isobutyl tiglate10.9210881092———0.36——166‐Camphenol11.7511111117———0.16——17Cystophorene11.9711191121————0.280.42182‐Methyl‐1‐butyl tiglate12.4511271130———0.29——19trans‐Sabinol12.87113711400.90.14—1.540.150.3720β‐Pinene oxide13.6011541156———0.08——215‐Pentylcyclohexa‐1,3‐diene13.6811561160—0.13————22Crypton14.8411831186—0.04—0.23——23Dodecane, 4,6‐dimethyl‐15.5412001211————0.14—24Isothujyl acetate15.9712131219———0.17——252‐Hydroxy‐1,8‐cineole16.4512421247—0.18—1.69——26Geranial dimethyl acetal18.3912641272—0.03————27Isoascaridole20.7813041306————0.2—284‐Vinyl‐guaiacol20.3613091309—0.75——0.37—29Valeranone22.8213701376——0.19———30β‐Patchoulene23.4713791383——0.08———31(−)‐cis‐β‐Elemene23.9213891398————0.09—32β‐Caryophyllene25.1314171418—0.191.96—0.160.7533(+)‐β‐Cedrene25.1914191421—0.11————34γ‐Elemene25.8514341432————0.18—35β‐Cedrene25.1914391435————0.09—36β‐Barbatene26.0914401442—0.21——0.18—37Selina‐4,11‐diene27.0814711476——0.19———38β‐Selinene28.1414891492—0.120.48———39β‐Bisabolene28.8115051508—0.03——0.12—40Cycloisolongifolene29.1215131517——1.3———41Acetoveratrone29.7215171520—0.19————422‐Hydroxycineole, isobutyrate29.7815191521—0.220.60.390.23—43Delta‐cadinene29.4915221524———0.720.17—44 Senkyunolide H 30.05 1530 1536 — 5.18 7.11 3.62 0.42 4.7 45Spathulenol31.7315771576—0.192.140.920.350.1746Spirojatamol31.7815881588—0.120.220.490.080.4347Globulol32.2715901592——0.39———48Neointermedeol32.9716101613——1.680.610.110.2149α‐epi‐7‐epi‐5‐Eudesmol35.6716221626——0.22——50γ‐Eudesmol33.8516301632——0.3——51Hinesol34.2216401645——0.92—0.1952Butyl phthalide34.49164716501.26———0.4553 Z‐Butylidenephthalide 35.42 1671 1655 1.85 8.65 45.39 13.11 8.5 11.3 54Valeranone35.5116741578—0.380.811.290.280.26551,4‐Naphthalenedione, 2‐ethyl‐37.5716751680—0.32—0.15—566‐epi‐Shyobunol36.0816881690——0.27———57Guaiac acetate37.7217121715—0.23———58 E‐Butylidenephthalide37.16171717192.362.761.091.672.52.559 Z‐Ligustilide 37.85 1734 1733 75.2 62.83 30.2 47.7 70.54 61.4 60 E‐Ligustilide 40.05 1796 1798 3.99 6.98 3.43 4.23 4.02 5.6 61Panaxynone42.0918741880—0.05——— Total % 92.64 95.06 98.97 94.15 97.42 91.48 Phthalide derivative % 84.66 86.4 87.22 70.33 86.43 85.5 Note: Mode of identification a = linear retention indices (LRI) determined with reference to homologous series of n‐alkanes (C9–C24), coinjection with standards, b = MS Library search (NIST and WILLEY), MS literature data of major compounds. Bold type indicates major components (biochemical marker s). LRI: Linear retention index on Rtx‐5 column.John Wiley & Sons, Ltd. Terpenoid composition of Himalayan Angelica glauca root oil originating from different geographical regions. Note: Mode of identification a = linear retention indices (LRI) determined with reference to homologous series of n‐alkanes (C9–C24), coinjection with standards, b = MS Library search (NIST and WILLEY), MS literature data of major compounds. Bold type indicates major components (biochemical marker s). LRI: Linear retention index on Rtx‐5 column. Structures of the major active phthalide derivatives of Himalayan Angelica glauca. Response Surface Methodology (RSM) Analysis Final Equation in Terms of Coded Factors: ZOI=56.82−18.85A−113.79B+108.60C−11.84D−1.74E[1]+18.65E[2]+7.35E[3]+9.70E[4]−177.29AB+178.92AC−2.88AE[1]+0.5697AE[2]−0.8676AE[3]+0.1387AE[4]−3.35BE[1]+4.31BE[2]+1.37BE[3]+2.54BE[4]+0.2496CE[1]+0.6101CE[2]−0.8540CE[3]+0.5995CE[4]+0.1602DE[1]−4.47DE[2]−1.98DE[3]−2.54DE[4] Note: AD, BC, BD, CD, and the quadratic terms A2, B2, C2 and D2 were aliased (coefficient = 0.0000) and could not be independently estimated from the current design and are omitted from interpretation of the fitted equation above. Response surface analysis of ZOI was performed using a Box–Behnken design incorporating four quantitative factors (Z‐butylidenephthalide, Z‐ligustilide, temperature, time) and one categorical factor (pathogen, five levels). The fitted model was not statistically significant (F = 1.57, p = 0.3598), indicating that within the tested experimental space the selected model terms did not account for zone of inhibition (ZOI) variability beyond what would be expected from random error (Figure 2). Although the coefficient of determination was high (R 2 = 0.9106), the substantial divergence from the adjusted R 2 (0.3298) points to model over‐fitting relative to the available residual degrees of freedom (4), a consequence of the categorical factor's five levels combined with multiple two‐factor interactions saturating the design. Several higher‐order and interaction terms (AD, BC, BD, CD and all quadratic terms) were aliased and could not be independently estimated, and variance inflation factors for terms A, B, C, AB and AC were extremely elevated (103–105), reflecting severe multicollinearity among these predictors. The predicted R 2 could not be computed, and Adeq Precision (4.456) only marginally exceeded the minimum threshold of 4, together indicating limited predictive reliability of the current model. On this basis, the present dataset does not support a validated quantitative RSM optimization of ZOI as a function of the tested factors; the results should be interpreted as preliminary/exploratory, and individual factor trends discussed qualitatively rather than as statistically confirmed drivers of antimicrobial activity (Tables 3, 4, 5, 6). Predicted versus actual values of ZOI (diagnostic plots). TABLE 3ANOVA for the selected response surface model (response: ZOI).SourceSum of squaresdfMean square F‐value p‐ValueProb > F Model24.57260.94511.570.3598Not significantA: Z‐Butylidenephthalide0.282010.28200.46790.5315B: Z‐Ligustilide1.8811.883.110.1525C: Temperature0.729210.72921.210.3331D: Time0.003710.00370.00620.9411E: Pathogen4.9141.232.040.2537AB1.6411.642.720.1743AC1.6611.662.750.1728ADAliasedAE2.6940.67201.110.4593BCAliasedBDAliasedBE6.2841.572.600.1884CDAliasedCE1.8140.45350.75220.6053DE5.3641.342.220.2293A2 AliasedB2 AliasedC2 AliasedD2 Aliased Residual 2.41 40.6028Lack‐of‐fit2.4130.8038Pure error0.000010.0000 Cor total 26.98 30Fit statisticsStd. Dev.0.7764 R 2 0.9106Mean7.11Adjusted R 2 0.3298C.V. %10.92Predicted R 2 NA 1 Adeq Precision4.4560 Note: Model terms shown as “Aliased” could not be independently estimated from the current design; 1Predicted R2 could not be calculated (see Fit Statistics). 1 Predicted R2 not defined — PRESS could not be reliably computed given the high‐leverage design points (see Table 3/diagnostics).John Wiley & Sons, Ltd. ANOVA for the selected response surface model (response: ZOI). Note: Model terms shown as “Aliased” could not be independently estimated from the current design; 1Predicted R2 could not be calculated (see Fit Statistics). Predicted R2 not defined — PRESS could not be reliably computed given the high‐leverage design points (see Table 3/diagnostics). TABLE 4Coefficients in terms of coded factors, with 95% CI and variance inflation factors.TermCoefficient estimatedfStandard error95% CI low95% CI highVIF Intercept 56.82133.73−36.82150.46A−18.85111.59−51.0413.34 2329.60 B−113.79167.72−301.8274.23 100 500 C108.60165.33−72.78289.98 193 700 D−11.8418.16−34.4910.811615.74E[1]−1.7416.75−20.4716.99E[2]18.6516.75−0.076337.38E[3]7.3516.75−11.3826.08E[4]9.7016.75−9.0328.43AB−177.291107.44−475.58121.00 75 982.77 AC178.921107.95−120.80478.64 227 000 ADAliasedAE[1]−2.8811.70−7.591.84AE[2]0.569711.70−4.155.29AE[3]−0.867611.70−5.583.85AE[4]0.138711.70−4.584.86BCAliasedBDAliasedBE[1]−3.3511.90−8.631.93BE[2]4.3111.90−0.97119.59BE[3]1.3711.90−3.916.65BE[4]2.5411.90−2.747.82CDAliasedCE[1]0.249610.7013−1.702.20CE[2]0.610110.7013−1.342.56CE[3]−0.854010.7013−2.801.09CE[4]0.599510.7013−1.352.55DE[1]0.160211.70−4.564.88DE[2]−4.4711.70−9.190.2559DE[3]−1.9811.70−6.702.74DE[4]−2.5411.70−7.262.18A2 AliasedB2 AliasedC2 AliasedD2 Aliased Note: Shaded rows (A, B, C, AB, and AC) indicate variance inflation factors far in excess of the conventional threshold (VIF > 10), signalling severe multicollinearity; coefficients for these terms should not be interpreted individually.John Wiley & Sons, Ltd. Coefficients in terms of coded factors, with 95% CI and variance inflation factors. Note: Shaded rows (A, B, C, AB, and AC) indicate variance inflation factors far in excess of the conventional threshold (VIF > 10), signalling severe multicollinearity; coefficients for these terms should not be interpreted individually. TABLE 5Prediction of actual data.Run orderActual valuePredicted valueResidualLeverageStandard order184.6684.6601.000( 1 ) 5286.486.401.000( 1 ) 4387.2287.2201.000( 1 ) 1470.3370.3301.000( 1 ) 3586.4386.4301.000( 1 ) 2685.585.501.000( 1 ) 6John Wiley & Sons, Ltd. Prediction of actual data. TABLE 6ANOVA for 2FI model.SourceSum of squaresdfMean square F‐value p‐Value Model 209.59541.92A: Temperature129.611129.61B: Time195.061195.06D‐D190.73363.58 Cor total 209.595 Std. Dev.NA( 1 ) R 2 1 Mean 83.42 Adjusted R 2 NA( 1 ) C.V. % NA( 1 ) Predicted R 2 NA( 1 ) Note: Different AG samples, showing clear chemical differentiation among the samples.John Wiley & Sons, Ltd. ANOVA for 2FI model. Note: Different AG samples, showing clear chemical differentiation among the samples. The optimised conditions identified in this study, involving Z‐butylidenephthalide (A), Z‐ligustilide (B), extraction temperature (C), extraction time (D), and pathogen type (E), provide an efficient strategy for maximizing ZOI (Figures 3 and 4). These findings have important implications for enhancing the antimicrobial efficacy and industrial utilization of phthalide‐containing aromatic plants. Equation 1 is BBD equation. (1) Y=β0+∑i=1kβiXi+∑i=1kβiiXi2+∑i